AIMC Topic: Antineoplastic Agents

Clear Filters Showing 441 to 450 of 592 articles

Identifying predictive features in drug response using machine learning: opportunities and challenges.

Annual review of pharmacology and toxicology
This article reviews several techniques from machine learning that can be used to study the problem of identifying a small number of features, from among tens of thousands of measured features, that can accurately predict a drug response. Prediction ...

Novel reliable model by integrating the discrete wavelet transform with fuzzy intelligent systems for the simultaneous spectrophotometric determination of anticancer drug and anti-acquired resistance drug in biological samples.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Simultaneous measurement of drugs used to treat cancer and medications prescribed to overcome resistance to these drugs is important in pharmaceutical formulations and biological samples. In this study, a spectrophotometric method with a hybrid of di...

Comprehensive Analysis of Epigenetic Signatures in Non-Small Cell Lung Cancer: Development and Validation of an Epigenetics-Based Prognostic Model for Drug Sensitivity Prediction.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Non-small cell lung cancer (NSCLC) exhibits complex epigenetic dysregulation that impacts treatment response and prognosis, yet comprehensive analysis linking epigenetic signatures to clinical outcomes remains limited. We integrated single-cell RNA s...

Machine learning-driven programmed cell death signature for prognosis and drug candidate discovery in diffuse large B-cell lymphoma: Multi-cohort study and experimental validation.

International immunopharmacology
BACKGROUND: Relapse and drug resistance are major contributor to chemotherapy failure in diffuse large B-cell lymphoma (DLBCL). Programmed cell death (PCD), a key mechanism in tumor progression and resistance, has emerged as a promising biomarker for...

Machine learning models for predicting chemotherapy-induced adverse drug reactions in colorectal cancer patients.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
BACKGROUND: Chemotherapy-induced adverse drug reactions (ADRs) are common in patients with colorectal cancer. We developed four machine learning models to predict chemotherapy-induced ADRs and assessed the performance. These models leverage high-dime...

EnsemPred-ACP: Combining machine and deep learning to improve anticancer peptide prediction.

Computers in biology and medicine
Anticancer peptide (ACP) has emerged as potent therapeutic agents owing to its ability to selectively target cancer cells while minimising toxicity to healthy cells. However, the accurate computational prediction of ACP remains challenging because of...

Genetic features for drug responses in cancer - Investigating an ensemble-feature-selection approach.

Computers in biology and medicine
Predicting drug responses using genetic and transcriptomic features is crucial for enhancing personalized medicine. In this study, we implemented an ensemble of machine learning algorithms to analyze the correlation between genetic and transcriptomic...

Role of artificial intelligence in cancer drug discovery and development.

Cancer letters
The role of artificial intelligence (AI) in cancer drug discovery and development has garnered significant attention due to its potential to transform the traditionally time-consuming and expensive processes involved in bringing new therapies to mark...